DMII

10.2300.20%
SE

Saleem Elmasri

CFO & Secretary

Mr. Saleem Elmasri, CPA, is Chief Financial Officer of Starton Therapeutics Inc. from September 2026. He serves as Chief Financial Officer at Starton Holdings, Inc. since 2026. He is CFO & Principal Accounting Officer of Drugs Made In America Acquisition Corp. from November 17, 2025. He has been Chief Financial Officer and Principal Accounting Officer of Drugs Made In America Acquisition II Corp. since November 17, 2025. He Mr. Elmasri served as Chief Financial Officer at Bright Green Corp. since March 2022 until December 20, 2024. He served as Director of Trans American Aquaculture since March 2024 until December 9, 2024. He was Director of Liberty Star Uranium & Metals Corp. since August 16, 2023 until 2025 and served as the Member of Advisory Board from December 2025 to September 2026. He serves as Chief Financial Officer and Secretary at Jupiter Neurosciences, Inc. since January 1, 2023. He is Director of Blockchain of Things, Inc. since August 4, 2021. He worked as Senior Manager for PricewaterhouseCoopers LLP from September 2007 to March 2018. He worked as Senior Director for Pine Hill Group LLC from March 2018 to June 2019 and as Managing Director at DLA LLC from June 2019 to April 2021. Mr. Elmasri has been working at Titan Advisory Services LLC as Principal since September 2020. In 2023, he launched Titan Strategic Partners to help clients navigate project financing for ambitious infrastructure ventures. Mr. Elmasri was Managing Director at DLA LLC from June 2019 to April 2021 (ended full time employment September 2020 and became a consultant to DLA through April 2021). Mr. Elmasri is a Certified Public Accountant (CPA) and seasoned business professional who has a passion for delivering meaningful and measurable value to clients through practical solutions. Mr. Elmasri has experience in financial and management consulting. Mr. Elmasri began his career at PricewaterhouseCoopers and worked on several of the firm’s Fortune 500 clients, primarily focused on the Life Sciences and Pharmaceutical industry. From PwC, Mr. Elmasri transitioned to lead advisory practices at boutique consulting firms, specializing in transaction and complex accounting advisory. Mr. Elmasri has B.S. degrees in Accounting and Finance from Rutgers University in 2007.

公司职务